aTYR PHARMA INC Common Stock, Value, Issued
aTYR PHARMA INC (ATYR) had Common Stock, Value, Issued of $98.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $98.00K.
- 2026-03-31: Common Stock, Value, Issued $98.00K.
- 2025-12-31: Common Stock, Value, Issued $98.00K.
- 2025-09-30: Common Stock, Value, Issued $98.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $98.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $98.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $98.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $98.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $93.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $89.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $84.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $76.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $76.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $68.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $63.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $59.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $57.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $53.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $29.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $29.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $28.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $28.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $28.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $28.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $16.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $16.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $11.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $10.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $9.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $4.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $50.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $49.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $37.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.00K 10-K · filed 2020-03-26 | $31.00K 10-K · filed 2019-03-26 |
| 2018-09-30 | $30.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $30.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $30.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $30.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $30.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $24.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $24.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $24.00K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $24.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $24.00K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $24.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $24.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $24.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $24.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $1.00K 10-Q · filed 2015-06-18 | |
| 2014-12-31 | $1.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |